Highlights & Insights

The vaunted ability of pharmaceutical companies to name their own price is vanishing as middlemen increasingly call the shots.

Surveying the clinical trial landscape.

To vaccinate, or not to vaccinate? That is the question.

Estimated effectiveness of COVID-19 prevention based on interim data from late stage clinical trials.

The UK government's aim is to reach 15 million of the most vulnerable by mid-February - and 14 million have been vaccinated so far.

Four companies that agreed to pay a combined $26 billion to settle claims about their roles in the U.S. opioid crisis plan to deduct some of those costs from their taxes and recoup around $1 billion apiece.

For Brussels, the optics are not so favourable, as the world sees an EU candidate country conspicuously benefiting from its ties to the East.

The European Commission has closed its excessive pricing investigation into Aspen, after the drugmaker committed to reduce the price of six of its cancer medicines.

South Africa's decision to halt its rollout of the Oxford-AstraZeneca vaccine may have left the nation in shock, but it also shows how scientists are at the forefront of the battle against coronavirus.

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2026.

Usually in January, every year, a large number of pharmaceutical companies update product prices - a trend that often receives public attention in the media, for better or for worse.

The following are the 20 most expensive medications in the U.S., based on the list price — the price a manufacturer assigns as the official price of a drug.